E-LIB Suche - Ergebnisse für: Azie, Nkechi

1

Real-World Analysis of Oral Fluconazole 150 mg Prescribing ..:

Sulham, Kate ; Falcon, Ron ; Azie, Nkechi
American Journal of Obstetrics and Gynecology. 226 (2022) 2 - p. 323 , 2022

Link: https://doi.org/10.1016/..

2

P057 All- cause mortality in patients with invasive Candidi..:

Prattes, Juergen ; King, Thomas ; Azie, Nkechi.
Medical Mycology. 60 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

3

Oral Ibrexafungerp Outcomes in Subjects With Refractory Vul..:

Goje, Oluwatosin ; King, Thomas ; Angulo, David.
Obstetrics & Gynecology. 139 (2022) 1 - p. 36S-36S , 2022

Link: https://doi.org/10.1097/..

4

Efficacy and Safety of Oral Ibrexafungerp in Subjects with ..:

Sobel, Jack ; Nyirjesy, Paul ; Falcon, Ron...
American Journal of Obstetrics and Gynecology. 226 (2022) 2 - p. 290 , 2022

Link: https://doi.org/10.1016/..

5

P056 Oral Ibrexafungerp outcomes by fungal disease in patie..:

Prattes, Juergen ; King, Thomas ; Azie, Nkechi.
Medical Mycology. 60 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

6

871. Oral Ibrexafungerp Outcomes by Fungal Disease in Patie..:

Thompson, George R ; King, Thomas ; Azie, Nkechi..
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

7

Outcomes in Subpopulations from Pooled Phase 3 Clinical Stu..:

Goje, Tosin ; Falcon, Ron ; Azie, Nkechi..
American Journal of Obstetrics and Gynecology. 226 (2022) 2 - p. 290 , 2022

Link: https://doi.org/10.1016/..

8

466. All-Cause Mortality in Patients with Invasive Candidia..:

Prattes, Juergen ; King, Thomas ; Azie, Nkechi.
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

9

992. Oral Ibrexafungerp Outcomes in Patients with Oropharyn..:

Vazquez, Jose A ; Cornely, Oliver ; Koehler, Philipp...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S586-S587 , 2021

Link: https://doi.org/10.1093/..

10

123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patie..:

Pappas, Peter G ; Cornely, Oliver ; Koehler, Philipp...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S73-S74 , 2021

Link: https://doi.org/10.1093/..

11

983. Outcomes of Candida Bone and Joint Infections in Eight..:

Sanders, John W ; Morse, Caryn ; Cornely, Oliver...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S583-S583 , 2021

Link: https://doi.org/10.1093/..

12

In VitropH Activity of Ibrexafungerp against Fluconazole-Su..:

Sobel, Jack D. ; Borroto-Esoda, Katyna ; Azie, Nkechi.
Antimicrobial Agents and Chemotherapy. 65 (2021) 8 - p. , 2021

Link: https://doi.org/10.1128/..

13

1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp..:

Borroto-Esoda, Katyna ; Azie, Nkechi ; Ashbaugh, Alan..
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S643-S643 , 2020

Link: https://doi.org/10.1093/..

14

Oral Ibrexafungerp: an investigational agent for the treatm..:

Azie, Nkechi ; Angulo, David ; Dehn, Barbara.
Expert Opinion on Investigational Drugs. 29 (2020) 9 - p. 893-900 , 2020

Link: https://doi.org/10.1080/..

15

1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patie..:

Alexander, Barbara D ; Cornely, Oliver ; Pappas, Peter...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S642-S642 , 2020

Link: https://doi.org/10.1093/..